GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Shanghai Conant Optical Co 2276.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

35.78

+0.28%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Shanghai Conant Optical Co

Its shares trade on HKEX under the ticker 2276.HK. It has been listed since 16 December 2021. In the fiscal year to 31 December 2025, it reported revenue of CN¥2.55bn and net income of CN¥649.4m. At that date it held total assets of CN¥4.13bn and shareholders' equity of CN¥3.20bn.

Shanghai Conant Optical Co., Ltd. engages in business of manufacturing and sale of resin spectacle lenses. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-12-16. The firm produces a variety of resin glasses, including standardized lenses and customized lenses. The firm's products are exported to the United States, Japan, India, Australia, Thailand, Germany, Brazil and other countries and regions.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
16 Dec 2021
Employees
2,533

Leadership

Pay as last reported

  • Mr. Zhengxiang FeiExecutive Chairman of the Board, since 2018CN¥1.2m
  • Mr. Junhua ChenDeputy General Manager, Executive Director, since 2019CN¥667,000
  • Mr. Guoping XiaDeputy General Manager, Executive Director, since 2021CN¥797,000
  • Mr. Huyin XuFinancial Controller
  • Mr. Yuhong ZhengDeputy General Director, Executive Director, since 2019CN¥827,000
  • Ms. Xue CaoExecutive Director, Joint Company Secretary, since 2021
  • Mr. Chuanbao WangExecutive Director, since 2024
  • Mr. Pui Hang ChanJoint Company Secretary
  • Mr. Kehan TianNon-Executive Director
  • Ms. Xiaoyun ZhaoNon-Executive Director
  • Mr. Yi ChenNon-Executive Independent DirectorCN¥86,000
  • Mr. Yiting JinIndependent Non-Executive DirectorCN¥57,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Manufacturing and sale of resin spectacle lenses in Shanghai, China.
  • Employing 2,533 full-time employees in the Health Care sector.
  • Exporting to the United States, Japan, India, Australia, Thailand, Germany, and Brazil.

Weaknesses

  • IPO on 16 December 2021 with limited market history.
  • Headquartered in Shanghai, China, facing potential supply chain disruptions.
  • Limited product range beyond resin spectacle lenses.

Opportunities

  • Expanding into new markets like Germany and Brazil for increased sales.
  • Growing demand for customized lenses in the global Health Care sector.
  • Increasing exports to countries such as Japan and Australia.

Threats

  • Dependence on resin spectacle lens manufacturing with no diversification.
  • Competition from other manufacturers in the Health Care sector.
  • Economic fluctuations in key export markets like the United States and Germany.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.